Consensus Petco Health and Wellness Company, Inc.

Equities

WOOF

US71601V1052

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.51 ^USD	0.00%		-9.04%	-52.22%

Apr. 09	Petco Health and Wellness Company, Inc. Announces Termination of Employment of Darren MacDonald, Chief Customer Officer, Effective as of April 12, 2024	CI
Apr. 02	Sector Update: Consumer Stocks Fall in Late Afternoon Trading	MT

Evolution of the average Target Price on Petco Health and Wellness Company, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a72586d043cb2.jAh8puqyc5EU1rCvyuVY6b32_fwg3Rvwo4_Oixocdow._XwS04veOuFhnfLEr6QC0dallqVsuHi4wrrj6nJeJdzAWAbzmPUA4ljg5Q~9736c1f0c991652b68189db89135bef6

Analyst Recommendations on Petco Health and Wellness Company, Inc.

Petco Health & Wellness Shares Down on BofA Downgrade	Apr. 02	MT
BofA Securities Downgrades Petco Health & Wellness to Underperform From Buy, Cuts PT to $1.50 From $5 on 85% Expected EPS Cut	Apr. 02	MT
UBS Trims Petco Health & Wellness Price Target to $2.50 From $3, Maintains Neutral Rating	Mar. 20	MT
Evercore ISI Trims Price Target on Petco Health & Wellness to $3 From $4, Maintains In-Line Rating	Mar. 15	MT
RBC Cuts Price Target on Petco Health & Wellness to $2.70 From $3.50, Keeps Outperform Rating	Mar. 15	MT
Baird Trims Petco Health & Wellness Price Target to $2.50 From $3, Maintains Neutral Rating	Mar. 14	MT
Wedbush Adjusts Petco Health & Wellness' PT to $3 From $3.50, Keeps Outperform Rating	Mar. 14	MT
Morgan Stanley Cuts Price Target on Petco Health & Wellness to $3 From $5, Maintains Equal-Weight Rating	Dec. 04	MT
RBC Halves Price Target on Petco Health & Wellness to $3.50 From $7, Keeps Outperform Rating	Dec. 04	MT
UBS Adjusts Petco Health & Wellness Price Target to $2.75 From $5.50, Maintains Neutral Rating	Nov. 30	MT
Baird Downgrades Petco Health & Wellness to Neutral From Outperform, Trims Price Target to $3 From $8	Nov. 30	MT
Goldman Sachs Trims Price Target on Petco Health & Wellness to $5 From $7, Maintains Buy Rating	Nov. 30	MT
Wedbush Trims Price Target on Petco Health & Wellness to $3.50 From $4.50, Maintains Outperform Rating	Nov. 30	MT
Wells Fargo Downgrades Petco Health & Wellness to Equal Weight From Overweight, Cuts Price Target to $3 From $7	Nov. 29	MT
Wedbush Trims Petco Health & Wellness' PT to $4.50 From $6 on Near-Term Pressures, Keeps Outperform Rating	23-10-31	MT
Wolfe Research Starts Petco Health & Wellness at Peer Perform	23-09-29	MT
Goldman Sachs Cuts Price Target on Petco Health & Wellness to $7 From $12, Maintains Buy Rating	23-08-28	MT
RBC Trims Price Target on Petco Health & Wellness Company to $7 From $10, Maintains Outperform Rating	23-08-25	MT
UBS Adjusts Petco Health & Wellness Price Target to $5.50 From $9, Maintains Neutral Rating	23-08-25	MT
Wells Fargo Adjusts Price Target on Petco Health & Wellness to $7 From $11, Maintains Overweight Rating	23-08-25	MT
Citigroup Adjusts Price Target on Petco Health & Wellness to $5.50 From $8.50, Maintains Neutral Rating	23-08-25	MT
BNP Paribas Adjusts Price Target on Petco Health & Wellness to $4 From $6, Maintains Underperform Rating	23-08-25	MT
Morgan Stanley Cuts Price Target on Petco Health & Wellness to $5 From $9, Maintains Equalweight Rating	23-08-25	MT
Wedbush Lowers Petco Health & Wellness' Price Target to $6 From $9, Says Course Correction to Pressure Margins; Keeps Outperform Rating	23-08-25	MT
Needham Adjusts Price Target on Petco Health & Wellness Company to $8 From $12, Maintains Buy Rating	23-08-25	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1.51 USD

Average target price

2.996 USD

Spread / Average Target

+98.44%

High Price Target

6 USD

Spread / Highest target

+297.35%

Low Price Target

1 USD

Spread / Lowest Target

-33.77%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Petco Health and Wellness Company, Inc.

BofA Securities
UBS
Evercore ISI
RBC Capital Markets
Baird
Wedbush
Morgan Stanley
Goldman Sachs
Wells Fargo Securities
Wolfe Research
Citigroup
BNP Paribas Exane
Needham & Co.
Gordon Haskett
Jefferies & Co.
Credit Suisse
Exane BNP Paribas
Guggenheim

Ratings for Petco Health and Wellness Company, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar